Policy & Regulation
17 November 2026 - Swedish biopharmaceutical company Sobi (STO: SOBI), which focuses on rare diseases, said on Tuesday that the European Commission has approved Tryngolza (olezarsen) for adults with s...
17 November 2026 - Norwegian biotech company Oncoinvent ASA (OSE:ONCIN) on Tuesday reported favourable safety and tolerability results from the first interim safety analysis of its randomised phase 2 ...
17 November 2026 - Biotechnology company Rakuten Medical Inc announced on Monday that it has initiated a Phase 1 clinical trial of RM-0256 photoimmunotherapy in Japan.RM-0256, an anti-PD-L1 antibody-l...
17 November 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) said on Tuesday that its Japanese partner Eisai Co Ltd (TYO:4523) has presented new five-year data from the Clarit...
17 November 2026 - Chinese pharmaceutical company Akeso Inc (HKEX:9926) announced on Monday that China's National Medical Products Administration (NMPA) has accepted its supplemental New Drug App...
17 November 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Monday that Alexion, AstraZeneca Rare Disease's Klygefa (gefurulimab) has been approved in bot...